glp 1 agonist saxenda Teva brings first generic GLP-1 to US market with copycat approval Prescription Weight Loss Medications: How

The review contextualised native GLP-1 as the reference molecule for the entire dual GIP/GLP-1 receptor agonist research field including tirzepatide (approved) and novel triple agonists targeting GLP-1R, GIPR, and GCGR simultaneously confirming native GLP-1s ongoing research importance as the pharmacological anchor of this rapidly expanding compound class

This article talks about a triple agonist that works with glucagon receptors, which should make you burn more calories than incretin-only methods do

Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Aldosterone-to-Renin Ratio in Diabetic Patients With Hypertension: A Retrospective Observational Study

Its clear that we need more research evaluating the impact of these drugs on eating disorders outside of binge-eating disorders, but this could take a long time

vomiting & diarrhea)

Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and acute pancreatitis: A meta-analysis with trial sequential analysis